跳至主要内容
临床试验/NCT01359020
NCT01359020已完成4 期

Randomized, Open Label, Comparative, Parallel, Multicenter Trial to Determinate the Efficacy Anf Tolerability of Ibuprofen, Acetaminophen and Dipyrone Drops to Fever Control in Children

Mantecorp Industria Quimica e Farmaceutica Ltd.1 个研究点 分布在 1 个国家目标入组 396 人开始时间: 2007年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
396
试验地点
1
主要终点
Antipyretic efficacy

研究概览

简要总结

The purpose of this study was to compare the efficacy and tolerability of acetaminophen, dipyrone and ibuprofen to fever control in children.

For the efficacy asses were compared:

  • the time to start the action;
  • the action duration;
  • the difference between the basal temperature and the lower temperature in the study period.

For the tolerability asses all adverse events were recorded, as well as your intensity and the relation to the treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Months 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • male and female children aged 06 months to 06 years old, weight above 5 kilo and axillary temperature above 37,5 celsius degree.

排除标准

  • patients with a bad general heath state
  • patients with neoplasia, pepic ulcer, gastrointestinal bleeding,history of fever convulsion;
  • intolerant to dypirone, ibuprofen, acetaminophen or any other nonsteroidal antiinflammatory drug;
  • moderated or severe dehydration;
  • conscience state alteration;
  • not capable of ingest oral drugs;
  • patients being treated with steroids;
  • patients treated with antiinflammatory, analgesic and antipyretic drugs in the last 06 hours before the study.

研究组 & 干预措施

Acetaminophen

Active Comparator

10 milligram per kilo, oral administration

干预措施: ibuprofen, dipyrone, acetaminophen (Drug)

Dipyrone

Active Comparator

10 milligram per kilo, oral administration

干预措施: ibuprofen, dipyrone, acetaminophen (Drug)

Ibuprofen

Experimental

10 milligram per kilo, oral administration

干预措施: ibuprofen, dipyrone, acetaminophen (Drug)

结局指标

主要结局

Antipyretic efficacy

时间窗: Temperature was verified 15, 30, 45 and 60 minutes, 2, 3, 4, 5, 6, 7 and 8 hours after the administration of the drug.

The antipyretic efficacy was assessed comparing the time to the beggining of the action of the drugs, the difference between the final and inicial temperature and time of action.

次要结局

  • Adverse Events(Adverse Events were verified at 15, 30, 45 and 60 minutes, 2, 3, 4, 5, 6, 7 and 8 hours after the administration of the drug.)

研究者

发起方
Mantecorp Industria Quimica e Farmaceutica Ltd.
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Ibuprofen, Acetaminophen and Dipyrone to Fever... | 临床试验